Pacer Advisors, Inc. Travere Therapeutics, Inc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 1,037 shares of TVTX stock, worth $10,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,037
Previous 2,771
62.58%
Holding current value
$10,297
Previous $21,000
61.9%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$75.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$74.5 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$73.2 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$65.7 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$44.5 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $637M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...